During a Case-Based Roundtable® event, Matthew A. Lunning, DO, discussed the updated trial data for 2 chimeric antigen ...

A recent study compared two dosages of ifinatamab deruxtecan among patients with extensive-stage small cell lung cancer.

A study found omitting a course of antibiotic prophylaxis was non-inferior to the routinely administering antibiotics in ...

Schools can retool to make instruction more personalized and student-centered. But grading is a common sticking point.

During a Case-Based Roundtable® event, Laahn Foster, MD, discussed the 2024 update to the RELATIVITY-047 trial in advanced ...

The poly-metallic nature of our deposits offers the opportunity for PNRL to be competitive in multiple commodity markets, ...

The findings, in which doublet immunotherapy added to standard FOLFOX chemotherapy did not improve progression-free survival, ...

You've no doubt heard the phrase 'grade is king', and that's been the case for a long time when it comes to Australian copper ...

Adding Zynyz to carboplatin and paclitaxel prolonged the survival without progression in chemotherapy-naive recurrent or ...

Plinabulin/Docetaxel Combination Demonstrated Favorable Benefit/Risk Ratio over Docetaxel Alone: Significant Improvement in Overall Survival, Progression Free Survival, and Objective Response, with ...

Study findings support tivozanib monotherapy for second-line treatment of certain patients with metastatic RCC, an expert ...